血管アクセスデバイス市場 – 2030年までの世界予測

Report Overview

The global Vascular access device market is projected to reach USD 9.05 billion by 2030 from USD 5.99 billion in 2024, at a CAGR of 7.1% during the forecast period.

世界の血管アクセスデバイス市場は、予測期間中のCAGR 7.1%で、2024年の59億9,000万米ドルから2030年までに90億5,000万米ドルに達すると予測されています。

This is due to increasing adoption of minimally invasive procedure, as the adoption increases the demand for these devices rises. Additionally, increasing government support to build infrastructure for healthcare is increasing, thus rising the number of hospitals, consequently increasing the demand for the vascular access device. However, the high cost associated with replacement and maintenance of vascular access devices and increasing product recalls are the major restraint to the market. Additionally, the shortage of trained healthcare professionals & limited knowledge about the products is major challenge for the market growth. But is creating a conducive environment for market expansion over the forecast period of 2024-2030.

“The central venous access device segment of vascular access device market by type to hold largest position forecast period.”

Based on the product, the vascular access device market is divided into central venous access device, peripheral vascular access device, intraosseous access device, and accessories. Among these, in 2023 central venous access device segment account for the largest market share of XX% in vascular access device market. This is due to the rising prevalence of chronic diseases such as cancer, chronic kidney disease. Majority of the cancer patients will be given chemotherapy through these central venous access devices, as the chemotherapy drug are potent and should not be given through peripheral line. Thus, majority of the healthcare professionals prefer these devices. Thus, as the prevalence of these diseases is increasing the need for long-term treatment is rising, consequently increasing the demand for vascular access device market. Additionally, central venous access device has lesser adverse reactions compared to other vascular access devices thus fueling the segmental growth.

“The drug administration segment accounts for the largest market share in vascular access device market.”

Based on application, the vascular access device market is segmented into drug administration, fluid and nutrition administration, blood transfusion, and diagnostics & testing. The drug administration segment accounts for the largest market share in vascular access device market due to increasing hospitalization for diseases which require long term drug administration such as antibiotic therapy, pain management, chemotherapy and others. For instance, as per a research article, at least 25% of cancer patients undergo chemotherapy, thus increasing demand for implantable ports, peripherally inserted central catheters and tunneled catheters. Additionally, increasing adoption of tunneled catheters for hemodialysis is supporting the market growth, as these devices does not require any prior procedure to insert the device compared to their alternatives. This segment is again divided into chemotherapy and other drug administration. Among these, in 2023, other drug administration segment to hold the largest market share of XX% in vascular access device market by drug application. This is due to increased prevalence of diseases such as infectious diseases, chronic inflammatory diseases, cardiovascular diseases and among others.

“Asia Pacific accounted for the second largest share of the vascular access device market by region.”

The global vascular access device market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is the second largest regional market for vascular access device equipment and is estimated to grow at the highest CAGR during the forecast period. This is due to increasing prevalence of chronic diseases and rising geriatric population across the region.  For instance, as per Asia Development Bank, by 2050, one in four people in Asia and Pacific will be over 60 years old thus contributing to the market growth across the forecast period. Asia Pacific region includes Japan, China, India, Australia, South Korea and Rest of Asia Pacific. Among these, China accounts for the largest market share in vascular access device market in 2023. This is due to increasing aging population and rising number of cancer cases and hospital expansions contribute to the growing market. For instance, as per CEIC data, number of hospitals in China increased from 36,976 in 2022 to 38400 in 2023. As the number of hospitals increases, the demand for vascular access devices continues to grow, to support patients.

.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1–40%, Tier 2–30%, and Tier 3– 30%
• By Designation: C-level–50%, Director-level–30% and Others–20%
• By Region: North America–30%, Europe–25%, Asia Pacific–20%, Latin America- 15%, and Middle east and Africa – 10%

Note 1: Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The major players operating in the vascular access device market are Becton, Dickinson and Company (US), Teleflex Incorporated (US), ICU Medical, Inc. (US), B. Braun SE (Germany), AngioDynamics, Inc. (US), Medtronic, Plc (Ireland), Merit Medical Systems Inc. (US), Terumo Corporation (Japan), Nipro (Japan), Vygon (France), AMECATH (Egypt), Medical Components, Inc. (US), Healtline Medical Products (US), Cook (US), and Access Vascular, Inc. (US)

Research Coverage

This report studies the vascular access device market based on product, type, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

• Analysis of Key divers (Growing prevalence of lifestyle diseases, increasing number of chemotherapy procedures, growing use of vascular access devices in pediatric patients), restraints (High cost associated with placement and maintenance of vascular access device, product recalls and failures), Challenge (Shortage of skilled professionals, risks associated with vascular access devices), opportunity (Technological Advancements, growth in number of hospitals)
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the vascular access device market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the vascular access device market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the pain management devices market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

Table of Contents

1               INTRODUCTION              41

1.1           STUDY OBJECTIVES       41

1.2           MARKET DEFINITION   41

1.3           STUDY SCOPE   42

1.3.1        SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD                 42

1.3.2        INCLUSIONS & EXCLUSIONS       43

1.3.3        YEARS CONSIDERED      44

1.3.4        CURRENCY CONSIDERED            44

1.4           STAKEHOLDERS               45

1.5           SUMMARY OF CHANGES               45

2               RESEARCH METHODOLOGY       46

2.1           RESEARCH DATA              46

2.1.1        SECONDARY DATA          46

2.1.1.1    Objectives of secondary research       47

2.1.1.2    Key secondary sources         47

2.1.1.3    Key data from secondary sources       48

2.1.2        PRIMARY DATA 48

2.1.2.1    Key primary sources             49

2.1.2.2    Key objectives of primary research    49

2.1.2.3    Key data from primary sources           50

2.1.2.4    Key industry insights           51

2.2           MARKET SIZE ESTIMATION         52

2.2.1        SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)                 52

2.2.2        TOP-DOWN APPROACH                53

2.2.3        COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS      53

2.2.4        DEMAND-SIDE ANALYSIS             53

2.3           GROWTH FORECAST      54

2.4           DATA TRIANGULATION                57

2.5           MARKET RANKING ANALYSIS     58

2.6           STUDY ASSUMPTIONS  58

2.7           RESEARCH LIMITATIONS             58

2.7.1        METHODOLOGY-RELATED LIMITATIONS           58

2.7.2        SCOPE-RELATED LIMITATIONS                 59

2.8           RISK ANALYSIS  59

3               EXECUTIVE SUMMARY  60

4               PREMIUM INSIGHTS       68

4.1           VASCULAR ACCESS DEVICES MARKET OVERVIEW                 68

4.2           NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER

AND COUNTRY, 2023      69

4.3           GEOGRAPHIC SNAPSHOT OF VASCULAR ACCESS DEVICES MARKET, 2023 70

4.4           REGIONAL MIX: VASCULAR ACCESS DEVICES MARKET, 2024–2030 (USD MILLION)            71

4.5           VASCULAR ACCESS DEVICES MARKET: EMERGING VS. DEVELOPED MARKETS,

2024 VS. 2030 (USD MILLION)      71

5               MARKET OVERVIEW       72

5.1           INTRODUCTION              72

5.2           MARKET DYNAMICS       72

5.2.1        DRIVERS               73

5.2.1.1    Growing prevalence of lifestyle diseases           73

5.2.1.2    Increasing popularity of chemotherapy procedures

among cancer patients         73

5.2.1.3    Rising use of vascular access devices among pediatric patients                 73

5.2.2        RESTRAINTS      74

5.2.2.1    High cost of installation and maintenance of vascular access devices   74

5.2.2.2    Rising product recalls and failures     74

5.2.3        OPPORTUNITIES              75

5.2.3.1    Technological advancements              75

5.2.3.2    Increasing number of hospitals and expanding patient pool                 75

5.2.4        CHALLENGES    76

5.2.4.1    Shortage of skilled healthcare professionals     76

5.2.4.2    Risks associated with use of vascular access devices       76

5.3           TECHNOLOGY ANALYSIS             77

5.3.1        KEY TECHNOLOGIES     77

5.3.1.1    Imaging and navigation technologies                77

5.3.1.2    Catheter securement and stabilization technologies       77

5.3.2        COMPLEMENTARY TECHNOLOGIES       77

5.3.2.1    AI and ML              77

5.3.3        ADJACENT TECHNOLOGIES       78

5.3.3.1    Infection control technologies            78

5.4           INDUSTRY TRENDS         78

5.4.1        MINIMALLY INVASIVE VASCULAR ACCESS PROCEDURES                 78

5.4.2        INNOVATIONS IN CATHETER MATERIALS AND COATINGS          78

5.5           VALUE CHAIN ANALYSIS               79

5.6           ECOSYSTEM ANALYSIS  80

5.6.1        ROLE IN ECOSYSTEM     81

5.7           SUPPLY CHAIN ANALYSIS             82

5.8           TRADE ANALYSIS             83

5.8.1        IMPORT DATA FOR HS CODE 901839       83

5.8.2        EXPORT DATA FOR HS CODE 901839       84

5.9           PORTER’S FIVE FORCES ANALYSIS           85

5.9.1        THREAT OF NEW ENTRANTS      87

5.9.2        THREAT OF SUBSTITUTES          87

5.9.3        BARGAINING POWER OF BUYERS             87

5.9.4        BARGAINING POWER OF SUPPLIERS       87

5.9.5        INTENSITY OF COMPETITIVE RIVALRY 87

5.10         KEY STAKEHOLDERS & BUYING CRITERIA            88

5.10.1      KEY STAKEHOLDERS IN BUYING PROCESS           88

5.10.2      KEY BUYING CRITERIA  89

5.11         REGULATORY ANALYSIS               89

5.11.1      REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  90

5.11.2      REGULATORY FRAMEWORK       92

5.11.2.1  North America      92

5.11.2.1.1                US           92

5.11.2.1.2                Canada   92

5.11.2.2  Europe   93

5.11.2.3  Asia Pacific            93

5.11.2.4  Latin America       93

5.11.2.5  Middle East & Africa            94

5.12         PATENT ANALYSIS          94

5.12.1      INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS            94

5.13         PRICING ANALYSIS          96

5.13.1      INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES,

BY KEY PLAYER, 2021–2023            96

5.13.2      INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES,

BY REGION, 2021–2023    97

5.14         KEY CONFERENCES & EVENTS, 2025–2026              98

5.15         ADJACENT MARKET ANALYSIS  99

5.15.1      VASCULAR CLOSURE DEVICES MARKET                99

5.16         UNMET NEEDS/END-USER EXPECTATIONS         100

5.17         TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS            101

5.18         INVESTMENT & FUNDING SCENARIO     101

5.19         IMPACT OF AI/GEN AI ON VASCULAR ACCESS DEVICES MARKET               102

6               VASCULAR ACCESS DEVICES MARKET, BY TYPE                 104

6.1           INTRODUCTION              105

6.2           CENTRAL VENOUS ACCESS DEVICES      105

6.2.1        PERIPHERALLY INSERTED CENTRAL CATHETERS                 108

6.2.1.1    Better durability and increased clinical utility for extended treatment plans to drive segment       108

6.2.2        TUNNELED CATHETERS               110

6.2.2.1    Lower risk of infection and superior longevity to support

segment growth    110

6.2.3        NON-TUNNELED CATHETERS   112

6.2.3.1    Non-tunneled catheters to be used in critical cases with limited peripheral access  112

6.2.4        IMPLANTABLE PORTS   114

6.2.4.1    Implantable conventional ports          117

6.2.4.1.1 Ability to provide reliable venous access with minimal maintenance to spur adoption            117

6.2.4.2    Implantable power injectable ports   119

6.2.4.2.1 Ability to accommodate high-flow fluids and increased demand for chemotherapy to propel market growth      119

6.3           PERIPHERAL VASCULAR ACCESS DEVICES           121

6.3.1        PERIPHERAL VENOUS ACCESS DEVICES                124

6.3.1.1    Peripheral intravenous catheters       127

6.3.1.1.1 Cost-effectiveness, ease of placement, and compatibility with different treatments to augment segment growth           127

6.3.1.2    Midline catheters  129

6.3.1.2.1 Ability to provide reliable medium-term intravenous access from one to four weeks to aid segment growth          129

6.3.1.3    Butterfly/Winged steel needles          131

6.3.1.3.1 Precision and comfort in short-term venous access procedures to drive segment        131

6.3.2        PERIPHERAL ARTERIAL ACCESS DEVICES             133

6.3.2.1    Critical role in continuous hemodynamic monitoring and blood sampling in acute care settings to propel segment growth             133

6.4           ACCESSORIES    135

6.4.1        NEED FOR ENHANCED FUNCTIONALITY, PATIENT SAFETY, AND PROCEDURAL EFFICIENCY TO DRIVE MARKET                 135

6.5           INTRAOSSEOUS VASCULAR ACCESS DEVICES     137

6.5.1        CRITICAL ROLE IN EMERGENCY SITUATIONS TO FUEL UPTAKE IN HIGH-STRESS HEALTHCARE FACILITIES       137

7               VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION         140

7.1           INTRODUCTION              141

7.2           INTRAVENOUS ROUTE OF INSERTION  141

7.2.1        RISING NEED FOR ADMINISTERING ESSENTIAL TREATMENTS DURING ACUTE CARE TO AID MARKET GROWTH                 141

7.3           SUBCUTANEOUS ROUTE OF INSERTION               143

7.3.1        REDUCED INFECTION RISK, BETTER PATIENT COMFORT, AND MINIMAL MAINTENANCE TO AUGMENT MARKET GROWTH          143

7.4           INTRAOSSEOUS ROUTE OF INSERTION 145

7.4.1        NEED FOR RAPID AND RELIABLE ACCESS IN CRITICAL EMERGENCIES

TO FUEL UPTAKE            145

8               VASCULAR ACCESS DEVICES MARKET, BY APPLICATION                 148

8.1           INTRODUCTION              149

8.2           DRUG ADMINISTRATION             150

8.2.1        CHEMOTHERAPY             152

8.2.1.1    Increased incidence of cancer and advancements in oncology care to drive segment   152

8.2.2        OTHER DRUG ADMINISTRATION             154

8.3           FLUID & NUTRITION ADMINISTRATION               156

8.3.1        INCREASING NEED FOR INTRAVENOUS THERAPY IN CHRONIC DISEASES TO SPUR MARKET GROWTH              156

8.4           BLOOD TRANSFUSION  158

8.4.1        FREQUENT NEED FOR BLOOD TRANSFUSION FOR THALASSEMIA AND LYMPHOMA TO BOOST MARKET GROWTH                 158

8.5           DIAGNOSTICS & TESTING            160

8.5.1        INCREASING RELIANCE ON ACCURATE DIAGNOSTIC IMAGING, FLUID TESTING, AND PATIENT MONITORING TO AID MARKET GROWTH          160

9               VASCULAR ACCESS DEVICES MARKET, BY END USER                 163

9.1           INTRODUCTION              164

9.2           HOSPITALS         164

9.2.1        PUBLIC HOSPITALS        165

9.2.1.1    Increasing demand for affordable healthcare services in emerging economies to drive segment                165

9.2.2        PRIVATE HOSPITALS      167

9.2.2.1    Rising demand for advanced healthcare services and high-quality treatment options to drive market     167

9.3           CLINICS & AMBULATORY CARE CENTERS             169

9.3.1        INCREASING DEMAND FOR OUTPATIENT PROCEDURES AND COST-EFFECTIVE TREATMENTS TO BOOST SEGMENT GROWTH             169

9.4           OTHER END USERS         171

10            VASCULAR ACCESS DEVICES MARKET, BY REGION                 174

10.1         INTRODUCTION              175

10.2         NORTH AMERICA             178

10.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 178

10.2.2      US           187

10.2.2.1  US to dominate North American vascular access devices market during forecast period          187

10.2.3      CANADA               194

10.2.3.1  Rising cancer prevalence and advanced research initiatives to

propel market growth           194

10.3         EUROPE               202

10.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      202

10.3.2      GERMANY           210

10.3.2.1  Rising obesity rates and growing geriatric population to augment market growth       210

10.3.3      UK          217

10.3.3.1  Increased disease burden to fuel uptake for advanced vascular access devices for better treatment procedures                217

10.3.4      FRANCE                224

10.3.4.1  Presence of vascular access device manufacturers and technological advancements to fuel market growth        224

10.3.5      ITALY    231

10.3.5.1  Strong government healthcare policies to boost market growth                 231

10.3.6      SPAIN    238

10.3.6.1  Growing geriatric population and rising incidence of chronic diseases to fuel market growth            238

10.3.7      REST OF EUROPE             244

10.4         ASIA PACIFIC     252

10.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 252

10.4.2      CHINA  261

10.4.2.1  Advanced healthcare infrastructure and high geriatric population to support market growth    261

10.4.3      INDIA    269

10.4.3.1  Rising governmental health expenditure and increasing incidence of chronic diseases to fuel market growth         269

10.4.4      JAPAN   276

10.4.4.1  Increased geriatric population and high prevalence of cancer to drive market          276

10.4.5      AUSTRALIA         283

10.4.5.1  Increased demand for hemodialysis and advancements in healthcare infrastructure to propel market growth          283

10.4.6      SOUTH KOREA  290

10.4.6.1  Rising burden of chronic diseases and increasing aged population to boost market growth        290

10.4.7      REST OF ASIA PACIFIC   298

10.5         LATIN AMERICA                305

10.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 305

10.5.2      BRAZIL 313

10.5.2.1  Growing cancer burden and rising need for long-term treatment for chronic patients to drive market  313

10.5.3      MEXICO                320

10.5.3.1  Increasing focus on dialysis for patients with chronic kidney diseases to drive adoption of advanced vascular access devices    320

10.5.4      REST OF LATIN AMERICA             327

10.6         MIDDLE EAST & AFRICA                334

10.6.1      MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 334

10.6.2      GCC COUNTRIES              342

10.6.2.1  Increasing healthcare investments and rising prevalence of chronic diseases to propel market growth         342

10.6.3      REST OF MIDDLE EAST & AFRICA             349

11            COMPETITIVE LANDSCAPE         357

11.1         INTRODUCTION              357

11.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            357

11.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET              357

11.3         REVENUE ANALYSIS, 2019–2023  359

11.4         MARKET SHARE ANALYSIS, 2023                 360

11.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023                 362

11.5.1      STARS   362

11.5.2      EMERGING LEADERS     362

11.5.3      PERVASIVE PLAYERS      362

11.5.4      PARTICIPANTS 363

11.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2023         364

11.5.5.1  Company footprint               364

11.5.5.2  Region footprint   365

11.5.5.3  Type footprint       366

11.5.5.4  Route of insertion footprint                 367

11.5.5.5  Application footprint            368

11.5.5.6  End-user footprint                369

11.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023        370

11.6.1      PROGRESSIVE COMPANIES         370

11.6.2      RESPONSIVE COMPANIES            370

11.6.3      DYNAMIC COMPANIES  370

11.6.4      STARTING BLOCKS         370

11.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023                 372

11.6.5.1  Detailed list of key startup/SME players          372

11.6.5.2  Competitive benchmarking of key emerging players/startups                 373

11.7         COMPANY VALUATION & FINANCIAL METRICS 373

11.7.1      FINANCIAL METRICS      373

11.7.2      COMPANY VALUATION 374

11.8         BRAND/PRODUCT COMPARISON             375

11.9         COMPETITIVE SCENARIO             376

11.9.1      PRODUCT LAUNCHES & APPROVALS     376

11.9.2      DEALS  377

11.9.3      OTHER DEVELOPMENTS              377

12            COMPANY PROFILES      378

12.1         KEY PLAYERS     378

12.1.1      BECTON, DICKINSON AND COMPANY   378

12.1.1.1  Business overview 378

12.1.1.2  Products offered   379

12.1.1.3  Recent developments           384

12.1.1.3.1                Deals      384

12.1.1.4  MnM view              385

12.1.1.4.1                Key strengths        385

12.1.1.4.2                Strategic choices   385

12.1.1.4.3                Weaknesses & competitive threats     385

12.1.2      TELEFLEX INCORPORATED        386

12.1.2.1  Business overview 386

12.1.2.2  Products offered   387

12.1.2.3  Recent developments           390

12.1.2.3.1                Product launches  390

12.1.2.3.2                Other developments             391

12.1.2.4  MnM view              391

12.1.2.4.1                Key strengths        391

12.1.2.4.2                Strategic choices   391

12.1.2.4.3                Weaknesses & competitive threats     391

12.1.3      ICU MEDICAL    392

12.1.3.1  Business overview 392

12.1.3.2  Products offered   393

12.1.3.3  Recent developments           396

12.1.3.3.1                Deals      396

12.1.3.4  MnM view              396

12.1.3.4.1                Key strengths        396

12.1.3.4.2                Strategic choices   396

12.1.3.4.3                Weaknesses & competitive threats     396

12.1.4      NIPRO   397

12.1.4.1  Business overview 397

12.1.4.2  Products offered   398

12.1.4.3  MnM view              399

12.1.4.3.1                Key strengths        399

12.1.4.3.2                Strategic choices   399

12.1.4.3.3                Weaknesses & competitive threats     399

12.1.5      ANGIODYNAMICS, INC. 400

12.1.5.1  Business overview 400

12.1.5.2  Products offered   401

12.1.5.3  Recent developments           402

12.1.5.3.1                Product approvals 402

12.1.5.3.2                Deals      402

12.1.5.4  MnM view              403

12.1.5.4.1                Key strengths        403

12.1.5.4.2                Strategic choices   403

12.1.5.4.3                Weaknesses & competitive threats     403

12.1.6      VYGON 404

12.1.6.1  Business overview 404

12.1.6.2  Products offered   404

12.1.7      TERUMO CORPORATION             411

12.1.7.1  Business overview 411

12.1.7.2  Products offered   413

12.1.8      MEDTRONIC PLC             414

12.1.8.1  Business overview 414

12.1.8.2  Products offered   415

12.1.9      COOK    417

12.1.9.1  Business overview 417

12.1.9.2  Products offered   417

12.1.10   B. BRAUN SE       419

12.1.10.1                 Business overview 419

12.1.10.2                 Products offered   420

12.1.10.3                 Recent developments           425

12.1.10.3.1             Product launches & approvals            425

12.1.10.3.2             Deals      426

12.1.11   MERIT MEDICAL SYSTEMS, INC.                427

12.1.11.1                 Business overview 427

12.1.11.2                 Products offered   428

12.1.11.3                 Recent developments           429

12.1.11.3.1             Deals      429

12.1.12   AMECATH           430

12.1.12.1                 Business overview 430

12.1.12.2                 Products offered   430

12.1.13   MEDICAL COMPONENTS, INC.  433

12.1.13.1                 Business overview 433

12.1.13.2                 Products offered   433

12.1.14   HEALTHLINE MEDICAL PRODUCTS        436

12.1.14.1                 Business overview 436

12.1.14.2                 Products offered   436

12.1.15   ACCESS VASCULAR, INC.               438

12.1.15.1                 Business overview 438

12.1.15.2                 Products offered   438

12.2         OTHER PLAYERS              439

12.2.1      ARGON MEDICAL DEVICES         439

12.2.2      PAKUMEDMEDICAL PRODUCTS GMBH 440

12.2.3    GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.                 441

12.2.4      PFM MEDICAL GMBH     442

12.2.5      MEDI-TECH DEVICES PVT. LTD.                443

12.2.6      KIMAL   444

12.2.7      POLYMEDICURE               445

12.2.8      DELTAMED        446

12.2.9      NEWTECH MEDICAL DEVICES PVT. LTD.              447

12.2.10   SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.                 448

13            APPENDIX           449

13.1         DISCUSSION GUIDE        449

13.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                457

13.3         CUSTOMIZATION OPTIONS        459

13.4         RELATED REPORTS         459

13.5         AUTHOR DETAILS           460

LIST OF TABLES

TABLE 1                VASCULAR ACCESS DEVICES MARKET: INCLUSIONS & EXCLUSIONS       43

TABLE 2                STANDARD CURRENCY CONVERSION RATES                 44

TABLE 3                VASCULAR ACCESS DEVICES MARKET: STUDY ASSUMPTIONS  58

TABLE 4                VASCULAR ACCESS DEVICES MARKET: RISK ANALYSIS            59

TABLE 5                VASCULAR ACCESS DEVICES MARKET: ROLE IN ECOSYSTEM       81

TABLE 6                IMPORT DATA FOR HS CODE 901839, BY COUNTRY, 2018–2023 (USD MILLION)     84

TABLE 7                EXPORT DATA FOR HS CODE 901839, BY COUNTRY, 2018–2023 (USD MILLION)     85

TABLE 8                VASCULAR ACCESS DEVICES MARKET: PORTER’S FIVE FORCES 85

TABLE 9                INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS            88

TABLE 10              KEY BUYING CRITERIA FOR VASCULAR ACCESS DEVICES              89

TABLE 11              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  90

TABLE 12              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  90

TABLE 13              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  91

TABLE 14              LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  91

TABLE 15              MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  92

TABLE 16              INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES,

BY KEY PLAYER, 2021–2023            97

TABLE 17              INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES,

BY REGION, 2021–2023    97

TABLE 18              VASCULAR ACCESS DEVICES MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026     98

TABLE 19              VASCULAR ACCESS DEVICES MARKET: UNMET NEEDS/END-USER EXPECTATIONS          100

TABLE 20              VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)            105

TABLE 21              VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)            105

TABLE 22              CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            106

TABLE 23              CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            106

TABLE 24              CENTRAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY,

2021–2023 (USD MILLION)            107

TABLE 25              CENTRAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY,

2024–2030 (USD MILLION)            108

TABLE 26              PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, BY COUNTRY,

2021–2023 (USD MILLION)            109

TABLE 27              PERIPHERALLY INSERTED CENTRAL CATHETERS MARKET, BY COUNTRY,

2024–2030 (USD MILLION)            110

TABLE 28             TUNNELED CATHETERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)            111

TABLE 29             TUNNELED CATHETERS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)            112

TABLE 30              NON-TUNNELED CATHETERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)     113

TABLE 31              NON-TUNNELED CATHETERS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)     114

TABLE 32              IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)       115

TABLE 33              IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)       115

TABLE 34              IMPLANTABLE PORTS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)            116

TABLE 35              IMPLANTABLE PORTS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)            117

TABLE 36              IMPLANTABLE CONVENTIONAL PORTS MARKET, BY COUNTRY,

2021–2023 (USD MILLION)            118

TABLE 37              IMPLANTABLE CONVENTIONAL PORTS MARKET, BY COUNTRY,

2024–2030 (USD MILLION)            119

TABLE 38              IMPLANTABLE POWER INJECTABLE PORTS MARKET, BY COUNTRY,

2021–2023 (USD MILLION)            120

TABLE 39              IMPLANTABLE POWER INJECTABLE PORTS MARKET, BY COUNTRY,

2024–2030 (USD MILLION)            121

TABLE 40              PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            122

TABLE 41              PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            122

TABLE 42              PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY COUNTRY,

2021–2023 (USD MILLION)            123

TABLE 43              PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY COUNTRY,

2024–2030 (USD MILLION)            124

TABLE 44              PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            125

TABLE 45              PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            125

TABLE 46              PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY,

2021–2023 (USD MILLION)            126

TABLE 47              PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY COUNTRY,

2024–2030 (USD MILLION)            127

TABLE 48              PERIPHERAL INTRAVENOUS CATHETERS MARKET, BY COUNTRY,

2021–2023 (USD MILLION)            128

TABLE 49              PERIPHERAL INTRAVENOUS CATHETERS MARKET, BY COUNTRY,

2024–2030 (USD MILLION)            129

TABLE 50              MIDLINE CATHETERS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)            130

TABLE 51              MIDLINE CATHETERS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)            131

TABLE 52             BUTTERFLY/WINGED STEEL NEEDLES MARKET, BY COUNTRY,

2021–2023 (USD MILLION)            132

TABLE 53             BUTTERFLY/WINGED STEEL NEEDLES MARKET, BY COUNTRY,

2024–2030 (USD MILLION)            133

TABLE 54              PERIPHERAL ARTERIAL ACCESS DEVICES MARKET, BY COUNTRY,

2021–2023 (USD MILLION)            134

TABLE 55              PERIPHERAL ARTERIAL ACCESS DEVICES MARKET, BY COUNTRY,

2024–2030 (USD MILLION)            135

TABLE 56              ACCESSORIES MARKET, BY COUNTRY, 2021–2023 (USD MILLION) 136

TABLE 57              ACCESSORIES MARKET, BY COUNTRY, 2024–2030 (USD MILLION) 137

TABLE 58              INTRAOSSEOUS VASCULAR ACCESS DEVICES MARKET, BY COUNTRY,

2021–2023 (USD MILLION)            138

TABLE 59              INTRAOSSEOUS VASCULAR ACCESS DEVICES MARKET, BY COUNTRY,

2024–2030 (USD MILLION)            139

TABLE 60              VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION,

2021–2023 (USD MILLION)            141

TABLE 61              VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION,

2024–2030 (USD MILLION)            141

TABLE 62              VASCULAR ACCESS DEVICES MARKET FOR INTRAVENOUS ROUTE OF INSERTION, BY COUNTRY, 2021–2023 (USD MILLION) 142

TABLE 63              VASCULAR ACCESS DEVICES MARKET FOR INTRAVENOUS ROUTE OF INSERTION, BY COUNTRY, 2024–2030 (USD MILLION) 143

TABLE 64              VASCULAR ACCESS DEVICES MARKET FOR SUBCUTANEOUS ROUTE OF INSERTION, BY COUNTRY, 2021–2023 (USD MILLION)       144

TABLE 65              VASCULAR ACCESS DEVICES MARKET FOR SUBCUTANEOUS ROUTE OF INSERTION, BY COUNTRY, 2024–2030 (USD MILLION)       145

TABLE 66              VASCULAR ACCESS DEVICES MARKET FOR INTRAOSSEOUS ROUTE OF INSERTION, BY COUNTRY, 2021–2023 (USD MILLION) 146

TABLE 67              VASCULAR ACCESS DEVICES MARKET FOR INTRAOSSEOUS ROUTE OF INSERTION, BY COUNTRY, 2024–2030 (USD MILLION) 147

TABLE 68              VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            149

TABLE 69              VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            149

TABLE 70              VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)                 150

TABLE 71              VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)                 150

TABLE 72              VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY COUNTRY, 2021–2023 (USD MILLION)            151

TABLE 73              VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY COUNTRY, 2024–2030 (USD MILLION)            152

TABLE 74              VASCULAR ACCESS DEVICES MARKET FOR CHEMOTHERAPY, BY COUNTRY,

2021–2023 (USD MILLION)            153

TABLE 75              VASCULAR ACCESS DEVICES MARKET FOR CHEMOTHERAPY, BY COUNTRY,

2024–2030 (USD MILLION)            154

TABLE 76              VASCULAR ACCESS DEVICES MARKET FOR OTHER DRUG ADMINISTRATION,

BY COUNTRY, 2021–2023 (USD MILLION)               155

TABLE 77              VASCULAR ACCESS DEVICES MARKET FOR OTHER DRUG ADMINISTRATION,

BY COUNTRY, 2024–2030 (USD MILLION)               156

TABLE 78              VASCULAR ACCESS DEVICES MARKET FOR FLUID & NUTRITION ADMINISTRATION, BY COUNTRY, 2021–2023 (USD MILLION)       157

TABLE 79              VASCULAR ACCESS DEVICES MARKET FOR FLUID & NUTRITION ADMINISTRATION, BY COUNTRY, 2024–2030 (USD MILLION)       158

TABLE 80              VASCULAR ACCESS DEVICES MARKET FOR BLOOD TRANSFUSION, BY COUNTRY, 2021–2023 (USD MILLION)                 159

TABLE 81              VASCULAR ACCESS DEVICES MARKET FOR BLOOD TRANSFUSION, BY COUNTRY, 2024–2030 (USD MILLION)                 160

TABLE 82              VASCULAR ACCESS DEVICES MARKET FOR DIAGNOSTICS & TESTING, BY COUNTRY, 2021–2023 (USD MILLION)            161

TABLE 83              VASCULAR ACCESS DEVICES MARKET FOR DIAGNOSTICS & TESTING, BY COUNTRY, 2024–2030 (USD MILLION)            162

TABLE 84              VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)                164

TABLE 85              VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)                164

TABLE 86              VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE,

2021–2023 (USD MILLION)            165

TABLE 87              VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE,

2024–2030 (USD MILLION)            165

TABLE 88              PUBLIC HOSPITALS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)            166

TABLE 89              PUBLIC HOSPITALS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)            167

TABLE 90              PRIVATE HOSPITALS MARKET, BY COUNTRY, 2021–2023 (USD MILLION)            168

TABLE 91              PRIVATE HOSPITALS MARKET, BY COUNTRY, 2024–2030 (USD MILLION)            169

TABLE 92              VASCULAR ACCESS DEVICES MARKET FOR CLINICS & AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2023 (USD MILLION)       170

TABLE 93              VASCULAR ACCESS DEVICES MARKET FOR CLINICS & AMBULATORY CARE CENTERS, BY COUNTRY, 2024–2030 (USD MILLION)       171

TABLE 94              VASCULAR ACCESS DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2023 (USD MILLION)                 172

TABLE 95              VASCULAR ACCESS DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2030 (USD MILLION)                 173

TABLE 96              VASCULAR ACCESS DEVICES MARKET, BY COUNTRY, 2021–2023 (USD MILLION)     176

TABLE 97              VASCULAR ACCESS DEVICES MARKET, BY COUNTRY 2024–2030 (USD MILLION)      177

TABLE 98              VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2030 (THOUSAND UNITS)  178

TABLE 99              NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY,

2021–2023 (USD MILLION)            179

TABLE 100            NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY,

2024–2030 (USD MILLION)            180

TABLE 101            NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            180

TABLE 102            NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            180

TABLE 103            NORTH AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            181

TABLE 104            NORTH AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            181

TABLE 105            NORTH AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE,

2021–2023 (USD MILLION)            181

TABLE 106            NORTH AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE,

2024–2030 (USD MILLION)            182

TABLE 107            NORTH AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)                 182

TABLE 108            NORTH AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)                 182

TABLE 109            NORTH AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)                 183

TABLE 110            NORTH AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)                 183

TABLE 111            NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)                 183

TABLE 112            NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)                 184

TABLE 113            NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            184

TABLE 114            NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            184

TABLE 115            NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION) 185

TABLE 116            NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION) 185

TABLE 117            NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            185

TABLE 118            NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            186

TABLE 119            NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)                 186

TABLE 120            NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)                 186

TABLE 121            US: KEY MACROINDICATORS     187

TABLE 122            US: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)                187

TABLE 123            US: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)                188

TABLE 124            US: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            188

TABLE 125            US: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            188

TABLE 126            US: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)            189

TABLE 127            US: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)            189

TABLE 128            US: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            189

TABLE 129            US: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            190

TABLE 130            US: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            190

TABLE 131            US: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            190

TABLE 132            US: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION,

2021–2023 (USD MILLION)            191

TABLE 133            US: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION,

2024–2030 (USD MILLION)            191

TABLE 134            US: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            191

TABLE 135            US: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            192

TABLE 136            US: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)                 192

TABLE 137            US: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)                 192

TABLE 138            US: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            193

TABLE 139            US: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            193

TABLE 140            US: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE,

2021–2023 (USD MILLION)            193

TABLE 141            US: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE,

2024–2030 (USD MILLION)            194

TABLE 142            CANADA: INDICATIVE LIST OF CLINICAL TRIALS CONDUCTED, 2022–2024                194

TABLE 143            CANADA: KEY MACROINDICATORS         195

TABLE 144            CANADA: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            195

TABLE 145            CANADA: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            195

TABLE 146            CANADA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            196

TABLE 147            CANADA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            196

TABLE 148            CANADA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                196

TABLE 149            CANADA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)                197

TABLE 150            CANADA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            197

TABLE 151            CANADA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            197

TABLE 152            CANADA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            198

TABLE 153            CANADA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            198

TABLE 154            CANADA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION,

2021–2023 (USD MILLION)            198

TABLE 155            CANADA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION,

2024–2030 (USD MILLION)            199

TABLE 156            CANADA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            199

TABLE 157            CANADA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            199

TABLE 158            CANADA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION,

BY TYPE, 2021–2023 (USD MILLION)         200

TABLE 159            CANADA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION,

BY TYPE, 2024–2030 (USD MILLION)         200

TABLE 160            CANADA: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            200

TABLE 161            CANADA: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            201

TABLE 162            CANADA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE,

2021–2023 (USD MILLION)            201

TABLE 163            CANADA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE,

2024–2030 (USD MILLION)            201

TABLE 164            EUROPE: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY,

2021–2023 (USD MILLION)            202

TABLE 165            EUROPE: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY,

2024–2030 (USD MILLION)            203

TABLE 166            EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            203

TABLE 167            EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            203

TABLE 168            EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            204

TABLE 169            EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            204

TABLE 170            EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                204

TABLE 171            EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)                205

TABLE 172            EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            205

TABLE 173            EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            205

TABLE 174            EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            206

TABLE 175            EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            206

TABLE 176            EUROPE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION,

2021–2023 (USD MILLION)            206

TABLE 177            EUROPE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION,

2024–2030 (USD MILLION)            207

TABLE 178            EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            207

TABLE 179            EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            207

TABLE 180            EUROPE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION,

BY TYPE, 2021–2023 (USD MILLION)         208

TABLE 181            EUROPE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION,

BY TYPE, 2024–2030 (USD MILLION)         208

TABLE 182            EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            208

TABLE 183            EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            209

TABLE 184            EUROPE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE,

2021–2023 (USD MILLION)            209

TABLE 185            EUROPE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE,

2024–2030 (USD MILLION)            209

TABLE 186            GERMANY: KEY MACROINDICATORS      210

TABLE 187            GERMANY: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            210

TABLE 188            GERMANY: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            211

TABLE 189            GERMANY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            211

TABLE 190            GERMANY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            211

TABLE 191            GERMANY: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                212

TABLE 192            GERMANY: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)                212

TABLE 193            GERMANY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            212

TABLE 194            GERMANY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            212

TABLE 195            GERMANY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            213

TABLE 196            GERMANY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            213

TABLE 197            GERMANY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)                 213

TABLE 198            GERMANY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)                 214

TABLE 199            GERMANY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            214

TABLE 200            GERMANY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            214

TABLE 201            GERMANY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION,

BY TYPE, 2021–2023 (USD MILLION)         215

TABLE 202            GERMANY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION,

BY TYPE, 2024–2030 (USD MILLION)         215

TABLE 203            GERMANY: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            215

TABLE 204            GERMANY: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            216

TABLE 205            GERMANY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)                 216

TABLE 206            GERMANY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)                 216

TABLE 207            UK: KEY MACROINDICATORS     217

TABLE 208            UK: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)                217

TABLE 209            UK: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)                218

TABLE 210            UK: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            218

TABLE 211            UK: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            218

TABLE 212            UK: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)            219

TABLE 213            UK: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)            219

TABLE 214            UK: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            219

TABLE 215            UK: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            219

TABLE 216            UK: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            220

TABLE 217            UK: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            220

TABLE 218            UK: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION,

2021–2023 (USD MILLION)            220

TABLE 219            UK: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION,

2024–2030 (USD MILLION)            221

TABLE 220            UK: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            221

TABLE 221            UK: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            221

TABLE 222            UK: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)                 222

TABLE 223            UK: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)                 222

TABLE 224            UK: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            222

TABLE 225            UK: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            223

TABLE 226            UK: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE,

2021–2023 (USD MILLION)            223

TABLE 227            UK: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE,

2024–2030 (USD MILLION)            223

TABLE 228            FRANCE: KEY MACROINDICATORS          224

TABLE 229            FRANCE: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            224

TABLE 230            FRANCE: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            225

TABLE 231            FRANCE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            225

TABLE 232            FRANCE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            225

TABLE 233            FRANCE: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                226

TABLE 234            FRANCE: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)                226

TABLE 235            FRANCE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            226

TABLE 236            FRANCE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            226

TABLE 237            FRANCE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            227

TABLE 238            FRANCE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            227

TABLE 239            FRANCE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION,

2021–2023 (USD MILLION)            227

TABLE 240            FRANCE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION,

2024–2030 (USD MILLION)            228

TABLE 241            FRANCE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            228

TABLE 242            FRANCE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            228

TABLE 243            FRANCE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION,

BY TYPE, 2021–2023 (USD MILLION)         229

TABLE 244            FRANCE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION,

BY TYPE, 2024–2030 (USD MILLION)         229

TABLE 245            FRANCE: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            229

TABLE 246            FRANCE: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            230

TABLE 247            FRANCE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE,

2021–2023 (USD MILLION)            230

TABLE 248            FRANCE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE,

2024–2030 (USD MILLION)            230

TABLE 249            ITALY: KEY MACROINDICATORS               231

TABLE 250            ITALY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)         231

TABLE 251            ITALY: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)         232

TABLE 252            ITALY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            232

TABLE 253            ITALY: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            232

TABLE 254          ITALY: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)            233

TABLE 255          ITALY: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)            233

TABLE 256            ITALY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            233

TABLE 257            ITALY: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            233

TABLE 258            ITALY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            234

TABLE 259            ITALY: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            234

TABLE 260            ITALY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION,

2021–2023 (USD MILLION)            234

TABLE 261            ITALY: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION,

2024–2030 (USD MILLION)            235

TABLE 262            ITALY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            235

TABLE 263            ITALY: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            235

TABLE 264            ITALY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION,

BY TYPE, 2021–2023 (USD MILLION)         236

TABLE 265            ITALY: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION,

BY TYPE, 2024–2030 (USD MILLION)         236

TABLE 266            ITALY: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            236

TABLE 267            ITALY: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            237

TABLE 268            ITALY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE,

2021–2023 (USD MILLION)            237

TABLE 269            ITALY: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE,

2024–2030 (USD MILLION)            237

TABLE 270            SPAIN: KEY MACROINDICATORS               238

TABLE 271            SPAIN: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            238

TABLE 272            SPAIN: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            239

TABLE 273            SPAIN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            239

TABLE 274            SPAIN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            239

TABLE 275          SPAIN: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)            240

TABLE 276          SPAIN: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)            240

TABLE 277            SPAIN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            240

TABLE 278            SPAIN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            240

TABLE 279            SPAIN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            241

TABLE 280            SPAIN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            241

TABLE 281            SPAIN: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION,

2021–2023 (USD MILLION)            241

TABLE 282            SPAIN: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION,

2024–2030 (USD MILLION)            242

TABLE 283            SPAIN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            242

TABLE 284            SPAIN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            242

TABLE 285            SPAIN: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION,

BY TYPE, 2021–2023 (USD MILLION)         243

TABLE 286            SPAIN: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION,

BY TYPE, 2024–2030 (USD MILLION)         243

TABLE 287            SPAIN: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            243

TABLE 288            SPAIN: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            244

TABLE 289            SPAIN: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE,

2021–2023 (USD MILLION)            244

TABLE 290            SPAIN: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE,

2024–2030 (USD MILLION)            244

TABLE 291            REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            245

TABLE 292            REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            245

TABLE 293            REST OF EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            246

TABLE 294            REST OF EUROPE: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            246

TABLE 295            REST OF EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE,

2021–2023 (USD MILLION)            246

TABLE 296            REST OF EUROPE: IMPLANTABLE PORTS MARKET, BY TYPE,

2024–2030 (USD MILLION)            247

TABLE 297            REST OF EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)                 247

TABLE 298            REST OF EUROPE: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)                 247

TABLE 299            REST OF EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)                 248

TABLE 300            REST OF EUROPE: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)                 248

TABLE 301            REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)                 248

TABLE 302            REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)                 249

TABLE 303            REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            249

TABLE 304            REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            249

TABLE 305            REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION) 250

TABLE 306            REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION) 250

TABLE 307            REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            250

TABLE 308            REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            251

TABLE 309            REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)                 251

TABLE 310            REST OF EUROPE: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)                 251

TABLE 311            ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY,

2021–2023 (USD MILLION)            254

TABLE 312            ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY,

2024–2030 (USD MILLION)            254

TABLE 313            ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            255

TABLE 314            ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            255

TABLE 315            ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            255

TABLE 316            ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            256

TABLE 317            ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE,

2021–2023 (USD MILLION)            256

TABLE 318            ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE,

2024–2030 (USD MILLION)            256

TABLE 319            ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            257

TABLE 320            ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            257

TABLE 321            ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            257

TABLE 322            ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            258

TABLE 323            ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)                 258

TABLE 324            ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)                 258

TABLE 325            ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            259

TABLE 326            ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            259

TABLE 327            ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION) 259

TABLE 328            ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION) 260

TABLE 329            ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            260

TABLE 330            ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            260

TABLE 331            ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)                 261

TABLE 332            ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)                 261

TABLE 333            CHINA: KEY MACROINDICATORS             262

TABLE 334            CHINA: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            262

TABLE 335            CHINA: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            262

TABLE 336            CHINA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            263

TABLE 337            CHINA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            263

TABLE 338            CHINA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                263

TABLE 339            CHINA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)                264

TABLE 340            CHINA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            264

TABLE 341            CHINA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            264

TABLE 342            CHINA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            265

TABLE 343            CHINA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            265

TABLE 344            CHINA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION,

2021–2023 (USD MILLION)            265

TABLE 345            CHINA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION,

2024–2030 (USD MILLION)            266

TABLE 346            CHINA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            266

TABLE 347            CHINA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            266

TABLE 348            CHINA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION,

BY TYPE, 2021–2023 (USD MILLION)         267

TABLE 349            CHINA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION,

BY TYPE, 2024–2030 (USD MILLION)         267

TABLE 350            CHINA: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            267

TABLE 351            CHINA: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            268

TABLE 352            CHINA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE,

2021–2023 (USD MILLION)            268

TABLE 353            CHINA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE,

2024–2030 (USD MILLION)            268

TABLE 354            INDIA: KEY MACROINDICATORS               269

TABLE 355            INDIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)         269

TABLE 356            INDIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)         270

TABLE 357            INDIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            270

TABLE 358            INDIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            270

TABLE 359          INDIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)            271

TABLE 360          INDIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)            271

TABLE 361            INDIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            271

TABLE 362            INDIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            271

TABLE 363            INDIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            272

TABLE 364            INDIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            272

TABLE 365            INDIA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION,

2021–2023 (USD MILLION)            272

TABLE 366            INDIA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION,

2024–2030 (USD MILLION)            273

TABLE 367            INDIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            273

TABLE 368            INDIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            273

TABLE 369            INDIA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION,

BY TYPE, 2021–2023 (USD MILLION)         274

TABLE 370            INDIA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION,

BY TYPE, 2024–2030 (USD MILLION)         274

TABLE 371            INDIA: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            274

TABLE 372            INDIA: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            275

TABLE 373            INDIA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE,

2021–2023 (USD MILLION)            275

TABLE 374            INDIA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE,

2024–2030 (USD MILLION)            275

TABLE 375            JAPAN: KEY MACROINDICATORS              276

TABLE 376            JAPAN: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            276

TABLE 377            JAPAN: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            277

TABLE 378            JAPAN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            277

TABLE 379            JAPAN: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            277

TABLE 380          JAPAN: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)            278

TABLE 381          JAPAN: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)            278

TABLE 382            JAPAN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            278

TABLE 383            JAPAN: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            279

TABLE 384            JAPAN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            279

TABLE 385            JAPAN: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            279

TABLE 386            JAPAN: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION,

2021–2023 (USD MILLION)            280

TABLE 387            JAPAN: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION,

2024–2030 (USD MILLION)            280

TABLE 388            JAPAN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            280

TABLE 389            JAPAN: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            281

TABLE 390            JAPAN: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION,

BY TYPE, 2021–2023 (USD MILLION)         281

TABLE 391            JAPAN: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION,

BY TYPE, 2024–2030 (USD MILLION)         281

TABLE 392            JAPAN: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            282

TABLE 393            JAPAN: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            282

TABLE 394            JAPAN: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE,

2021–2023 (USD MILLION)            282

TABLE 395            JAPAN: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE,

2024–2030 (USD MILLION)            283

TABLE 396            AUSTRALIA: KEY MACROINDICATORS   283

TABLE 397            AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            284

TABLE 398            AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            284

TABLE 399            AUSTRALIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            284

TABLE 400            AUSTRALIA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            285

TABLE 401            AUSTRALIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                285

TABLE 402            AUSTRALIA: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)                285

TABLE 403            AUSTRALIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            286

TABLE 404            AUSTRALIA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            286

TABLE 405            AUSTRALIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            286

TABLE 406            AUSTRALIA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            287

TABLE 407            AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)                 287

TABLE 408            AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)                 287

TABLE 409            AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            288

TABLE 410            AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            288

TABLE 411            AUSTRALIA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION,

BY TYPE, 2021–2023 (USD MILLION)         288

TABLE 412            AUSTRALIA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION,

BY TYPE, 2024–2030 (USD MILLION)         289

TABLE 413            AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            289

TABLE 414            AUSTRALIA: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            289

TABLE 415            AUSTRALIA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)                 290

TABLE 416            AUSTRALIA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)                 290

TABLE 417            SOUTH KOREA: KEY MACROINDICATORS                 291

TABLE 418            SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            291

TABLE 419            SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            291

TABLE 420            SOUTH KOREA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            292

TABLE 421            SOUTH KOREA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            292

TABLE 422            SOUTH KOREA: IMPLANTABLE PORTS MARKET, BY TYPE,

2021–2023 (USD MILLION)            292

TABLE 423            SOUTH KOREA: IMPLANTABLE PORTS MARKET, BY TYPE,

2024–2030 (USD MILLION)            293

TABLE 424            SOUTH KOREA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)                 293

TABLE 425            SOUTH KOREA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)                 293

TABLE 426            SOUTH KOREA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            294

TABLE 427            SOUTH KOREA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            294

TABLE 428            SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)                 294

TABLE 429            SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)                 295

TABLE 430            SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            295

TABLE 431            SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            295

TABLE 432            SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION) 296

TABLE 433            SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION) 296

TABLE 434            SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            296

TABLE 435            SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            297

TABLE 436            SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)                 297

TABLE 437            SOUTH KOREA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)                 297

TABLE 438            REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            298

TABLE 439            REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            298

TABLE 440            REST OF ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)                 299

TABLE 441            REST OF ASIA PACIFIC: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)                 299

TABLE 442            REST OF ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE,

2021–2023 (USD MILLION)            299

TABLE 443            REST OF ASIA PACIFIC: IMPLANTABLE PORTS MARKET, BY TYPE,

2024–2030 (USD MILLION)            300

TABLE 444            REST OF ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET,

BY TYPE, 2021–2023 (USD MILLION)         300

TABLE 445            REST OF ASIA PACIFIC: PERIPHERAL VASCULAR ACCESS DEVICES MARKET,

BY TYPE, 2024–2030 (USD MILLION)         300

TABLE 446            REST OF ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)                 301

TABLE 447            REST OF ASIA PACIFIC: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)                 301

TABLE 448            REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET,

BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)      301

TABLE 449            REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET,

BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)      302

TABLE 450            REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)                 302

TABLE 451            REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)                 302

TABLE 452            REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)       303

TABLE 453            REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)       303

TABLE 454            REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)                 303

TABLE 455            REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)                 304

TABLE 456            REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS,

BY TYPE, 2021–2023 (USD MILLION)         304

TABLE 457            REST OF ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS,

BY TYPE, 2024–2030 (USD MILLION)         304

TABLE 458            LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY,

2021–2023 (USD MILLION)            305

TABLE 459            LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY COUNTRY,

2024–2030 (USD MILLION)            306

TABLE 460            LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            306

TABLE 461            LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            306

TABLE 462            LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            307

TABLE 463            LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            307

TABLE 464            LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE,

2021–2023 (USD MILLION)            307

TABLE 465            LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE,

2024–2030 (USD MILLION)            308

TABLE 466            LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)                 308

TABLE 467            LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)                 308

TABLE 468            LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            309

TABLE 469            LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            309

TABLE 470            LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)                 309

TABLE 471            LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)                 310

TABLE 472            LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            310

TABLE 473            LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            310

TABLE 474            LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION) 311

TABLE 475            LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION) 311

TABLE 476            LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            311

TABLE 477            LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            312

TABLE 478            LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)                 312

TABLE 479            LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)                 312

TABLE 480            BRAZIL: KEY MACROINDICATORS            313

TABLE 481            BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            313

TABLE 482            BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            314

TABLE 483            BRAZIL: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            314

TABLE 484            BRAZIL: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            314

TABLE 485            BRAZIL: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                315

TABLE 486            BRAZIL: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)                315

TABLE 487            BRAZIL: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            315

TABLE 488            BRAZIL: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            316

TABLE 489            BRAZIL: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            316

TABLE 490            BRAZIL: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            316

TABLE 491            BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION,

2021–2023 (USD MILLION)            317

TABLE 492            BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION,

2024–2030 (USD MILLION)            317

TABLE 493            BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            317

TABLE 494            BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            318

TABLE 495            BRAZIL: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION,

BY TYPE, 2021–2023 (USD MILLION)         318

TABLE 496            BRAZIL: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION,

BY TYPE, 2024–2030 (USD MILLION)         318

TABLE 497            BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            319

TABLE 498            BRAZIL: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            319

TABLE 499            BRAZIL: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE,

2021–2023 (USD MILLION)            319

TABLE 500            BRAZIL: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE,

2024–2030 (USD MILLION)            320

TABLE 501            MEXICO: KEY MACROINDICATORS          320

TABLE 502            MEXICO: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            321

TABLE 503            MEXICO: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            321

TABLE 504            MEXICO: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            321

TABLE 505            MEXICO: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            322

TABLE 506            MEXICO: IMPLANTABLE PORTS MARKET, BY TYPE, 2021–2023 (USD MILLION)                322

TABLE 507            MEXICO: IMPLANTABLE PORTS MARKET, BY TYPE, 2024–2030 (USD MILLION)                322

TABLE 508            MEXICO: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            323

TABLE 509            MEXICO: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            323

TABLE 510            MEXICO: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            323

TABLE 511            MEXICO: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            324

TABLE 512            MEXICO: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION,

2021–2023 (USD MILLION)            324

TABLE 513            MEXICO: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION,

2024–2030 (USD MILLION)            324

TABLE 514            MEXICO: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            325

TABLE 515            MEXICO: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            325

TABLE 516            MEXICO: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION,

BY TYPE, 2021–2023 (USD MILLION)         325

TABLE 517            MEXICO: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION,

BY TYPE, 2024–2030 (USD MILLION)         326

TABLE 518            MEXICO: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            326

TABLE 519            MEXICO: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            326

TABLE 520            MEXICO: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE,

2021–2023 (USD MILLION)            327

TABLE 521            MEXICO: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE,

2024–2030 (USD MILLION)            327

TABLE 522            REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            328

TABLE 523            REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            328

TABLE 524            REST OF LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)                 328

TABLE 525            REST OF LATIN AMERICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)                 329

TABLE 526            REST OF LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE,

2021–2023 (USD MILLION)            329

TABLE 527            REST OF LATIN AMERICA: IMPLANTABLE PORTS MARKET, BY TYPE,

2024–2030 (USD MILLION)            329

TABLE 528            REST OF LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET,

BY TYPE, 2021–2023 (USD MILLION)         330

TABLE 529            REST OF LATIN AMERICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET,

BY TYPE, 2024–2030 (USD MILLION)         330

TABLE 530            REST OF LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET,

BY TYPE, 2021–2023 (USD MILLION)         330

TABLE 531            REST OF LATIN AMERICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET,

BY TYPE, 2024–2030 (USD MILLION)         331

TABLE 532            REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET,

BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)      331

TABLE 533            REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET,

BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)      331

TABLE 534            REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)                 332

TABLE 535            REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)                 332

TABLE 536            REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)       332

TABLE 537            REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)       333

TABLE 538            REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)                 333

TABLE 539            REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)                 333

TABLE 540            REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)            334

TABLE 541            REST OF LATIN AMERICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)            334

TABLE 542            MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY REGION,

2021–2023 (USD MILLION)            335

TABLE 543            MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY REGION,

2024–2030 (USD MILLION)            335

TABLE 544            MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            335

TABLE 545            MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            336

TABLE 546            MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)                 336

TABLE 547            MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)                 336

TABLE 548            MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE,

2021–2023 (USD MILLION)            337

TABLE 549            MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE,

2024–2030 (USD MILLION)            337

TABLE 550            MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET,

BY TYPE, 2021–2023 (USD MILLION)         337

TABLE 551            MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET,

BY TYPE, 2024–2030 (USD MILLION)         338

TABLE 552            MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET,

BY TYPE, 2021–2023 (USD MILLION)         338

TABLE 553            MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET,

BY TYPE, 2024–2030 (USD MILLION)         338

TABLE 554            MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET,

BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)      339

TABLE 555            MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET,

BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)      339

TABLE 556            MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2021–2023 (USD MILLION)                 339

TABLE 557            MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION, 2024–2030 (USD MILLION)                 340

TABLE 558            MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)       340

TABLE 559            MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)       340

TABLE 560            MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2021–2023 (USD MILLION)                 341

TABLE 561            MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY END USER, 2024–2030 (USD MILLION)                 341

TABLE 562            MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS,

BY TYPE, 2021–2023 (USD MILLION)         341

TABLE 563            MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS,

BY TYPE, 2024–2030 (USD MILLION)         342

TABLE 564            GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            343

TABLE 565            GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            343

TABLE 566            GCC COUNTRIES: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2021–2023 (USD MILLION)            343

TABLE 567            GCC COUNTRIES: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE,

2024–2030 (USD MILLION)            344

TABLE 568            GCC COUNTRIES: IMPLANTABLE PORTS MARKET, BY TYPE,

2021–2023 (USD MILLION)            344

TABLE 569            GCC COUNTRIES: IMPLANTABLE PORTS MARKET, BY TYPE,

2024–2030 (USD MILLION)            344

TABLE 570            GCC COUNTRIES: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)                 345

TABLE 571            GCC COUNTRIES: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)                 345

TABLE 572            GCC COUNTRIES: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)                 345

TABLE 573            GCC COUNTRIES: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)                 346

TABLE 574            GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)                 346

TABLE 575            GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)                 346

TABLE 576            GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2021–2023 (USD MILLION)            347

TABLE 577            GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY APPLICATION,

2024–2030 (USD MILLION)            347

TABLE 578            GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION) 347

TABLE 579            GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION) 348

TABLE 580            GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2021–2023 (USD MILLION)            348

TABLE 581            GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET, BY END USER,

2024–2030 (USD MILLION)            348

TABLE 582            GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION)                 349

TABLE 583            GCC COUNTRIES: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION)                 349

TABLE 584            REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)                 350

TABLE 585            REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)                 350

TABLE 586            REST OF MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)            350

TABLE 587            REST OF MIDDLE EAST & AFRICA: CENTRAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)            351

TABLE 588            REST OF MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE,

2021–2023 (USD MILLION)            351

TABLE 589            REST OF MIDDLE EAST & AFRICA: IMPLANTABLE PORTS MARKET, BY TYPE,

2024–2030 (USD MILLION)            351

TABLE 590            REST OF MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)            352

TABLE 591            REST OF MIDDLE EAST & AFRICA: PERIPHERAL VASCULAR ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)            352

TABLE 592            REST OF MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2021–2023 (USD MILLION)            352

TABLE 593            REST OF MIDDLE EAST & AFRICA: PERIPHERAL VENOUS ACCESS DEVICES MARKET, BY TYPE, 2024–2030 (USD MILLION)            353

TABLE 594            REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET,

BY ROUTE OF INSERTION, 2021–2023 (USD MILLION)      353

TABLE 595            REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET,

BY ROUTE OF INSERTION, 2024–2030 (USD MILLION)      353

TABLE 596            REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET,

BY APPLICATION, 2021–2023 (USD MILLION)       354

TABLE 597            REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET,

BY APPLICATION, 2024–2030 (USD MILLION)       354

TABLE 598            REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2021–2023 (USD MILLION)                354

TABLE 599            REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR DRUG ADMINISTRATION, BY TYPE, 2024–2030 (USD MILLION)                355

TABLE 600            REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET,

BY END USER, 2021–2023 (USD MILLION)               355

TABLE 601            REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET,

BY END USER, 2024–2030 (USD MILLION)               355

TABLE 602            REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2021–2023 (USD MILLION) 356

TABLE 603            REST OF MIDDLE EAST & AFRICA: VASCULAR ACCESS DEVICES MARKET FOR HOSPITALS, BY TYPE, 2024–2030 (USD MILLION) 356

TABLE 604            OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN VASCULAR

ACCESS DEVICES MARKET           357

TABLE 605            VASCULAR ACCESS DEVICES MARKET: DEGREE OF COMPETITION           361

TABLE 606            VASCULAR ACCESS DEVICES MARKET: REGION FOOTPRINT       365

TABLE 607            VASCULAR ACCESS DEVICES MARKET: TYPE FOOTPRINT       366

TABLE 608            VASCULAR ACCESS DEVICES MARKET: ROUTE OF INSERTION FOOTPRINT        367

TABLE 609            VASCULAR ACCESS DEVICES MARKET: APPLICATION FOOTPRINT         368

TABLE 610            VASCULAR ACCESS DEVICES MARKET: END-USER FOOTPRINT            369

TABLE 611            VASCULAR ACCESS DEVICES MARKET: DETAILED LIST OF

KEY STARTUP/SME PLAYERS      372

TABLE 612            VASCULAR ACCESS DEVICES MARKET: COMPETITIVE BENCHMARKING OF

KEY EMERGING PLAYERS/STARTUPS     373

TABLE 613            VASCULAR ACCESS DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025        376

TABLE 614            VASCULAR ACCESS DEVICES MARKET: DEALS, JANUARY 2021–JANUARY 2025     377

TABLE 615            VASCULAR ACCESS DEVICES MARKET: OTHER DEVELOPMENTS,

JANUARY 2021–JANUARY 2025     377

TABLE 616            BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW   378

TABLE 617            BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED    379

TABLE 618            BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021–JANUARY 2025     384

TABLE 619            TELEFLEX INCORPORATED: COMPANY OVERVIEW          386

TABLE 620            TELEFLEX INCORPORATED: PRODUCTS OFFERED             387

TABLE 621            TELEFLEX INCORPORATED: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025             390

TABLE 622            TELEFLEX INCORPORATED: OTHER DEVELOPMENTS,

JANUARY 2021–JANUARY 2025     391

TABLE 623            ICU MEDICAL: COMPANY OVERVIEW     392

TABLE 624            ICU MEDICAL: PRODUCTS OFFERED      393

TABLE 625            ICU MEDICAL: DEALS, JANUARY 2021–JANUARY 2025        396

TABLE 626            NIPRO: COMPANY OVERVIEW   397

TABLE 627            NIPRO: PRODUCTS OFFERED    398

TABLE 628            ANGIODYNAMICS, INC.: COMPANY OVERVIEW                 400

TABLE 629            ANGIODYNAMICS, INC.: PRODUCTS OFFERED                 401

TABLE 630            ANGIODYNAMICS, INC.: PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025     402

TABLE 631            ANGIODYNAMICS, INC.: DEALS, JANUARY 2021–JANUARY 2025    402

TABLE 632            VYGON: COMPANY OVERVIEW 404

TABLE 633            VYGON: PRODUCTS OFFERED  404

TABLE 634            TERUMO CORPORATION: COMPANY OVERVIEW          411

TABLE 635            TERUMO CORPORATION: PRODUCTS OFFERED                 413

TABLE 636            MEDTRONIC PLC: COMPANY OVERVIEW                 414

TABLE 637            MEDTRONIC PLC: PRODUCTS OFFERED                 415

TABLE 638            COOK: COMPANY OVERVIEW    417

TABLE 639            COOK: PRODUCTS OFFERED     417

TABLE 640            B. BRAUN SE: COMPANY OVERVIEW       419

TABLE 641            B. BRAUN SE: PRODUCTS OFFERED        420

TABLE 642            B. BRAUN SE: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2021–JANUARY 2025     425

TABLE 643            B. BRAUN SE: DEALS, JANUARY 2021–JANUARY 2025        426

TABLE 644            MERIT MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW          427

TABLE 645            MERIT MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED             428

TABLE 646            MERIT MEDICAL SYSTEMS, INC.: DEALS, JANUARY 2021–JANUARY 2025     429

TABLE 647            AMECATH: COMPANY OVERVIEW            430

TABLE 648            AMECATH: PRODUCTS OFFERED             430

TABLE 649            MEDICAL COMPONENTS, INC.: COMPANY OVERVIEW          433

TABLE 650            MEDICAL COMPONENTS, INC.: PRODUCTS OFFERED             433

TABLE 651            HEALTHLINE MEDICAL PRODUCTS: COMPANY OVERVIEW          436

TABLE 652            HEALTHLINE MEDICAL PRODUCTS: PRODUCTS OFFERED             436

TABLE 653            ACCESS VASCULAR, INC.: COMPANY OVERVIEW                 438

TABLE 654            ACCESS VASCULAR, INC.: PRODUCTS OFFERED                 438

TABLE 655            ARGON MEDICAL DEVICES: COMPANY OVERVIEW          439

TABLE 656            PAKUMEDMEDICAL PRODUCTS GMBH: COMPANY OVERVIEW   440

TABLE 657            GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW              441

TABLE 658            PFM MEDICAL GMBH: COMPANY OVERVIEW                 442

TABLE 659            MEDI-TECH DEVICES PVT. LTD.: COMPANY OVERVIEW          443

TABLE 660            KIMAL: COMPANY OVERVIEW   444

TABLE 661            POLYMEDICURE: COMPANY OVERVIEW                 445

TABLE 662            DELTAMED: COMPANY OVERVIEW         446

TABLE 663            NEWTECH MEDICAL DEVICES PVT. LTD.: COMPANY OVERVIEW   447

TABLE 664            SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.: COMPANY OVERVIEW       448

LIST OF FIGURES

FIGURE 1              VASCULAR ACCESS DEVICES MARKET: SEGMENTS

CONSIDERED & GEOGRAPHICAL SPREAD            42

FIGURE 2              VASCULAR ACCESS DEVICES MARKET: YEARS CONSIDERED    44

FIGURE 3              VASCULAR ACCESS DEVICES MARKET: RESEARCH DESIGN         46

FIGURE 4              VASCULAR ACCESS DEVICES MARKET: KEY DATA FROM SECONDARY SOURCES        48

FIGURE 5              VASCULAR ACCESS DEVICES MARKET: KEY PRIMARY SOURCES         49

FIGURE 6              VASCULAR ACCESS DEVICES MARKET: KEY DATA FROM PRIMARY SOURCES               50

FIGURE 7              VASCULAR ACCESS DEVICES MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS     51

FIGURE 8              BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,

DESIGNATION, AND REGION     51

FIGURE 9              MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS            52

FIGURE 10            VASCULAR ACCESS DEVICES MARKET: TOP-DOWN APPROACH          53

FIGURE 11            MARKET SIZE ESTIMATION: DEMAND-SIDE ANALYSIS            54

FIGURE 12            IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN VASCULAR ACCESS DEVICES MARKET            55

FIGURE 13            VASCULAR ACCESS DEVICES MARKET: CAGR PROJECTIONS   55

FIGURE 14            VASCULAR ACCESS DEVICES MARKET: DATA TRIANGULATION             57

FIGURE 15            CENTRAL VENOUS ACCESS DEVICES TO ACCOUNT FOR LARGEST MARKET SHARE DURING STUDY PERIOD                60

FIGURE 16            TUNNELED CATHETERS TO GROW AT HIGHEST CAGR IN CENTRAL VENOUS ACCESS DEVICES MARKET FROM 2024 TO 2030       61

FIGURE 17            IMPLANTABLE POWER INJECTABLE PORTS TO REGISTER HIGHEST GROWTH RATE IN IMPLANTABLE PORTS MARKET DURING STUDY PERIOD            61

FIGURE 18            PERIPHERAL VENOUS ACCESS DEVICES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD       62

FIGURE 19            PERIPHERAL INTRAVENOUS CATHETERS TO COMMAND LARGEST MARKET SHARE DURING STUDY PERIOD                 63

FIGURE 20            INTRAVENOUS ROUTE OF INSERTION TO HOLD LARGEST MARKET SHARE

FROM 2024 TO 2030          63

FIGURE 21            DRUG ADMINISTRATION TO COMMAND LARGEST SHARE IN

APPLICATIONS SEGMENT            64

FIGURE 22            CHEMOTHERAPY TO BE FASTEST-GROWING SEGMENT DURING FORECAST PERIOD 65

FIGURE 23            HOSPITALS TO ACCOUNT FOR LARGEST MARKET SHARE

DURING FORECAST PERIOD       65

FIGURE 24            PUBLIC HOSPITALS TO COMMAND LARGER SHARE OF HOSPITALS MARKET DURING FORECAST PERIOD                 66

FIGURE 25            ASIA PACIFIC TO BE FASTEST-GROWING REGIONAL MARKET FOR

VASCULAR ACCESS DEVICES      67

FIGURE 26            RISING PREVALENCE OF CHRONIC DISEASES REQUIRING LONG-TERM TREATMENT AND CARE TO DRIVE MARKET               68

FIGURE 27            US AND HOSPITALS SEGMENT COMMANDED LARGEST MARKET SHARE IN 2023             69

FIGURE 28            ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD      70

FIGURE 29            ASIA PACIFIC TO COMMAND HIGHEST GROWTH RATE FROM 2024 TO 2030         71

FIGURE 30            EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES

DURING STUDY PERIOD               71

FIGURE 31            VASCULAR ACCESS DEVICES MARKET: DRIVERS, RESTRAINTS,

OPPORTUNITIES, AND CHALLENGES     72

FIGURE 32            VASCULAR ACCESS DEVICES MARKET: VALUE CHAIN ANALYSIS              80

FIGURE 33            VASCULAR ACCESS DEVICES MARKET: ECOSYSTEM ANALYSIS  80

FIGURE 34            VASCULAR ACCESS DEVICES MARKET: SUPPLY CHAIN ANALYSIS              83

FIGURE 35            VASCULAR ACCESS DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS           86

FIGURE 36            INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS            88

FIGURE 37            KEY BUYING CRITERIA FOR TOP THREE PRODUCT TYPES             89

FIGURE 38            NUMBER OF PATENT PUBLICATIONS (JANUARY 2014–DECEMBER 2024)   94

FIGURE 39            TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR VASCULAR ACCESS DEVICE PATENTS (JANUARY 2014−DECEMBER 2024)       95

FIGURE 40            TOP APPLICANT COUNTRIES/REGIONS FOR VASCULAR ACCESS DEVICES

(JANUARY 2014− DECEMBER 2024)           96

FIGURE 41            VASCULAR CLOSURE DEVICES MARKET: MARKET OVERVIEW       99

FIGURE 42            VASCULAR ACCESS DEVICES MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS                 101

FIGURE 43            VASCULAR ACCESS DEVICES MARKET: FUNDING AND NUMBER OF DEALS,

2019–2023              101

FIGURE 44            VASCULAR ACCESS DEVICES MARKET: IMPACT OF AI/GEN AI     103

FIGURE 45            VASCULAR ACCESS DEVICES MARKET: GEOGRAPHIC SNAPSHOT            175

FIGURE 46            NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET SNAPSHOT       179

FIGURE 47            ASIA PACIFIC: VASCULAR ACCESS DEVICES MARKET SNAPSHOT       253

FIGURE 48            REVENUE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS

DEVICES MARKET (2019–2023)    360

FIGURE 49            MARKET SHARE ANALYSIS OF KEY PLAYERS IN VASCULAR ACCESS

DEVICES MARKET (2023)               361

FIGURE 50            VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2023       363

FIGURE 51            VASCULAR ACCESS DEVICES MARKET: COMPANY FOOTPRINT 364

FIGURE 52            VASCULAR ACCESS DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023                 371

FIGURE 53            EV/EBITDA OF KEY VENDORS   373

FIGURE 54            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK

BETA OF KEY VENDORS                374

FIGURE 55            VASCULAR ACCESS DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS     375

FIGURE 56            BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT   379

FIGURE 57            TELEFLEX INCORPORATED: COMPANY SNAPSHOT          387

FIGURE 58            ICU MEDICAL: COMPANY SNAPSHOT     393

FIGURE 59            NIPRO: COMPANY SNAPSHOT   398

FIGURE 60            ANGIODYNAMICS, INC.: COMPANY SNAPSHOT                 401

FIGURE 61            TERUMO CORPORATION: COMPANY SNAPSHOT          412

FIGURE 62            MEDTRONIC PLC: COMPANY SNAPSHOT                 415

FIGURE 63            B. BRAUN SE: COMPANY SNAPSHOT       420

FIGURE 64            MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT          428

MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • ご注文後2営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

割引可能なレポートが多数ございます。価格・サンプルについてはお気軽にご相談ください。

最新調査レポート

• 尿失禁デバイス市場 – 2030年までの世界予測 2025-03-12
• 医療用加湿器市場 – 2029年までの世界予測 2025-03-11
• BOPETフィルム市場 – 2029年までの世界予測 2025-03-11
• 金ナノ粒子市場 – 2029年までの世界予測 2025-03-07
• 沈降シリカ市場 – 2030年までの世界予測 2025-03-07

MarketsandMarkets  出版レポート一覧